SimplyCash

ARKG has been adding - potential Inverse H&S. $22 Price Target

Long
NYSE:TAK   Takeda Pharmaceutical Company Limited
Looks like a low risk play. ARKG has been adding steadily over the recent months.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.